Atlas Capital Advisors’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-727
Closed -$1.45K 951
2022
Q3
$1.45K Buy
+727
New +$1.45K ﹤0.01% 851
2022
Q2
Sell
-727
Closed -$6.33K 1022
2022
Q1
$6.33K Hold
727
﹤0.01% 766
2021
Q4
$11.6K Hold
727
﹤0.01% 700
2021
Q3
$13.4K Hold
727
﹤0.01% 684
2021
Q2
$10.1K Buy
+727
New +$10.1K ﹤0.01% 741
2021
Q1
Sell
-1
Closed -$19 828
2020
Q4
$19 Buy
+1
New +$19 ﹤0.01% 644